Analysis Between Coronary Angiotomography and Sensitive Troponin in Intermediate Risk of Acute Coronary Syndrome
CONECTTIN
COmparative Prospective aNalysis betweEn Coronary angioTomography and Sensitive Troponin in Patients With Chest Pain and INtermediate Risk of Acute Coronary Syndrome in the Emergency Room - CONECTTIN Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
In recent years, a large number of studies have been conducted on how to improve the treatment of patients in the Emergency Room (ER) complaining of chest pains. Great advances have been achieved recently regarding diagnostic methods aided by coronary CT angiopraphy (CCTA) and sensitive troponins. However, various questions about these methods still remain obscure and there is no effective comparison between them in patients with intermediate risk. The aim of the study is to evaluate the sensitivity and specificity of sensitivity troponins in the detection of coronary artery disease in patients with chest pain and the intermediate probability of ACS compared with CCTA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 26, 2016
CompletedFirst Posted
Study publicly available on registry
May 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedFebruary 5, 2018
January 1, 2017
1.8 years
April 26, 2016
February 2, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Number of participants with adverse events according to phone contact after 30 days
Patients whose CCTAs show lesions with stenosis of less than 50%, compare combined outcomes (death, AMI, rehospitalization, and stroke)with the increase/decrease of troponin in the second measurement in 30 days according to phone contact.
30 days
Compare the sensitivity, specificity, and negative and positive predictive values between the high sensitivity troponin and the CCTA in the detection of an ACS.
ROC curve / ANOVA
30 days
Secondary Outcomes (1)
Stablish the cut off for troponin levels
3 hours
Study Arms (1)
Cases
EXPERIMENTALAll patients will be submmited to troponin measurements and CCTA. If CCTA shows coronary stenosis ≥ 50%, patient will initiate the ACS treatment and be hospitalized to have coronary cineangiography. If CCTA shows lesions \< 50%, the patient will be discharged and monitored for 30 days. A second sampling of the troponin will be obtained from all patients three hours after the first collection in order to evaluate for an increase/decrease of troponin.
Interventions
Cardiac catheterization (for patients with \>50% lesions) or discharge or in patients with intermediate risk.
Eligibility Criteria
You may qualify if:
- chest pain for at least two hours before arriving at the emergency unit
- non-diagnostic electrocardiogram (absence of new or probable deviation of ST of at least 0.5 mV and/or T wave inversion of at least 0.2 mV)
- TIMI risk of 3 or 4
- first measurement of troponin I less than or equal to ≤ 0.03 ng/ml
- informed consent form signed.
You may not qualify if:
- pregnancy
- hemodynamic instability (pulmonary congestion / systolic arterial pressure lower than 90 mmHg)
- serum creatinine higher than 1.5 mg/dL
- intolerance to ß-blockers
- allergy to iodinated contrast
- asthma
- thoracic trauma within the last 30 days
- body mass index greater than 40 kg/ m2
- previous surgical myocardial revascularization
- other identified causes of troponin increase
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto do Coração - HMFMUSP
São Paulo, 05403000, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2016
First Posted
May 16, 2016
Study Start
March 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2018
Last Updated
February 5, 2018
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share